In this respect, transcranial direct current stimulation, which activates signaling downstream BDNF and elicits LTP-like mechanisms in rats, improves episodic and semantic memories in AD patients (Cocco et al., 2018) a result in line with earlier findings showing that the blood-brain barrier permeable TrkB agonist 7,8-dihydroxyflavone (7,8-DHF) ameliorates cognitive decline in AD animal models (Devi and Ohno, 2012). Here, NTRK2 is linked to Alzheimer disease.